Mithra Pharmaceuticals
- Company typePrivate
- Founded1999
- HeadquartersLiège, Belgium
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Mithra Pharmaceuticals firmographics
Firmographics- Name
- Mithra Pharmaceuticals
- Legal name
- Mithra Pharmaceuticals SA
- Website
- https://mithra.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Mithra Pharmaceuticals industry classification
Industry- Product category
- Women's Health Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)
- akta.pro secondary industry
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
Keywords
Where Mithra Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Liège
- HQ country
- Belgium
- HQ region
- Europe
Markets served
Mithra Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Mithra Pharmaceuticals product offering
Product offeringCore offering
Mithra Pharmaceuticals is a Belgian biopharmaceutical company that develops and commercializes pharmaceutical products focused exclusively on women's health. Its portfolio targets two therapeutic areas: hormonal contraception and menopause/hormone replacement therapy (HRT), with named assets such as Donesta® under development for menopause treatment.
Product overview
Mithra is an AI-native Enterprise Marketing OS — a unified platform combining four integrated disciplines: Acquisition (paid media optimization), Lifecycle (agent-driven automation), CDP (managed data pipelines), and Analytics (AI insights and reporting). The platform centers on the M1 reasoning model, a proprietary marketing-specific AI fine-tuned on 2.4B first-party events with 128K token context. E1 serves as the Customer Data Platform foundation. M1 and E1 operate across all four disciplines to deliver autonomous campaign management, predictive segmentation, and real-time optimization. The platform is designed for enterprise marketing organizations requiring AI-powered decision-making at scale.
Differentiator
Problem solved
Functional benefit
Products and services
- Donesta®
Companies that use Mithra Pharmaceuticals
Customer profileSegments3 records
Ideal customer profiles3 records
Mithra Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Mithra Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Gedeon RichtermajorGedeon Richter acquired Estetra and Neuralis from Mithra Pharmaceuticals. This represents a strategic divestiture of certain business units by Mithra to Gedeon Richter, a pharmaceutical company.
Scale indicators3 records
Recent moves6 records
Expansion highlights3 records
Mithra Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Gedeon Richter Plc. Hungarian-headquartered pharma group with a major women's health franchise (contraception, HRT) and the acquirer of Mithra's Estetra and Neuralis units, making it a direct strategic peer and counterparty.
- Organon & Co. Pure-play women's health pharmaceutical company spun out of Merck, offering contraception, fertility, and menopause therapies. Closest publicly traded comparable given its exclusive focus on women's health and similar therapeutic portfolio.
- TherapeuticsMD, Inc. US women's health company commercializing hormone therapy and contraceptive products (e.g., Bijuva, Annovera). Operates in overlapping menopause/HRT and contraception categories.
Broad incumbents
- Bayer AG (Pharmaceuticals Division): Large pharmaceutical incumbent with leading women's health franchises including Mirena hormonal IUD and Yaz/Yasmin oral contraceptives, directly overlapping with Mithra's contraception and IUD focus areas.
- Endo International plc: Specialty pharma with women's health and endocrinology exposure (e.g., menopausal hormone therapies), overlapping with Mithra's HRT and reproductive health focus.
- Amneal Pharmaceuticals, Inc. Generic and specialty pharmaceutical manufacturer with exposure to women's health and hormone therapy categories, including generic oral contraceptives.
- AbbVie Inc. Major diversified pharma with women's health exposure (e.g., Lo Loestrin Fe, Orilissa) and significant commercial reach, competing in the same therapeutic areas with broader resources.
- Pfizer Inc. Global pharmaceutical incumbent with established women's health and contraceptive franchises, competing with Mithra in contraception and HRT markets.
Emerging players
- Daré Bioscience, Inc. Clinical-stage biopharmaceutical company developing women's health products across contraception, menopause, and reproductive health, with comparable therapeutic focus to Mithra.
- Agile Therapeutics, Inc. Smaller women's health company focused on hormonal contraceptive products (Twirla patch), competing in the contraceptive segment with Mithra.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Mithra Pharmaceuticals social profiles
Digital presenceMithra Pharmaceuticals compliance and trust
Trust signalCompliance3 records
Mithra Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mithra Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles2 records
Mithra Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mithra Pharmaceuticals M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mithra Pharmaceuticals
What does Mithra Pharmaceuticals do?
Mithra Pharmaceuticals is a Belgian biopharmaceutical company that develops and commercializes pharmaceutical products focused exclusively on women's health. Its portfolio targets two therapeutic areas: hormonal contraception and menopause/hormone replacement therapy (HRT), with named assets such as Donesta® under development for menopause treatment.
Is Mithra Pharmaceuticals a public or private company?
Mithra Pharmaceuticals is a private company. It is classified as public and is currently operating.
When was Mithra Pharmaceuticals founded?
Mithra Pharmaceuticals was founded in 1999. It employs 251 to 500 people.
Where is Mithra Pharmaceuticals based?
Mithra Pharmaceuticals is headquartered in Liège, Belgium, in the Europe region.
Who are Mithra Pharmaceuticals's main competitors?
Direct peers on record are Gedeon Richter Plc., Organon & Co. and TherapeuticsMD, Inc.. Broad incumbents are Bayer AG (Pharmaceuticals Division), Endo International plc, Amneal Pharmaceuticals, Inc., AbbVie Inc. and Pfizer Inc.. Emerging players are Daré Bioscience, Inc. and Agile Therapeutics, Inc..
Does Mithra Pharmaceuticals have an API?
No public API is recorded for Mithra Pharmaceuticals.
What industry is Mithra Pharmaceuticals in?
Mithra Pharmaceuticals's product category is Women's Health Pharmaceuticals. Its primary akta.pro industry code is HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 325412 and its SIC code is 2834.